{"id":337684,"date":"2025-08-19T12:33:23","date_gmt":"2025-08-19T12:33:23","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-novavax\/"},"modified":"2025-08-19T12:33:23","modified_gmt":"2025-08-19T12:33:23","slug":"how-to-buy-novavax","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-novavax\/","title":{"rendered":"Novavax, Inc. (NVAX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Novavax, Inc. (NVAX) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334027,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-337684","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Novavax, Inc. (NVAX) Hisseleri Nas\u0131l Al\u0131n\u0131r - Novavax, Inc. (NVAX) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Novavax, Inc. (NVAX) Hisseleri Nas\u0131l Al\u0131n\u0131r - Novavax, Inc. (NVAX) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Novavax, Inc. (NVAX) hisseleri nas\u0131l al\u0131n\u0131r ve ak\u0131ll\u0131 yat\u0131r\u0131m kararlar\u0131 nas\u0131l verilir \u00f6\u011frenin. G\u00fcncel hisse performans\u0131, risk analizi ve 2025-2030 b\u00fcy\u00fcme potansiyelini ke\u015ffedin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Novavax, Inc. (NVAX) hisseleri nas\u0131l al\u0131n\u0131r ve ak\u0131ll\u0131 yat\u0131r\u0131m kararlar\u0131 nas\u0131l verilir \u00f6\u011frenin. G\u00fcncel hisse performans\u0131, risk analizi ve 2025-2030 b\u00fcy\u00fcme potansiyelini ke\u015ffedin."},"intro":"A\u015f\u0131 end\u00fcstrisinde ses getiren bir biyoteknoloji \u015firketine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Novavax, Inc. (NVAX), b\u00fcy\u00fcyen sa\u011fl\u0131k sekt\u00f6r\u00fcyle ilgilenen yat\u0131r\u0131mc\u0131lar i\u00e7in heyecan verici bir f\u0131rsat sunuyor. \u00c7\u0131\u011f\u0131r a\u00e7an a\u015f\u0131 teknolojisi ve yak\u0131n zamanda al\u0131nan FDA onaylar\u0131yla, bu \u015firket size \u00f6nemli getiriler sa\u011flayabilir. Novavax'\u0131n neden dikkatinizi hak etti\u011fini ve b\u00fcy\u00fcme hikayelerinin bir par\u00e7as\u0131 nas\u0131l olabilece\u011finizi ke\u015ffedelim.","intro_source":{"label":"Intro","type":"text","formatted_value":"A\u015f\u0131 end\u00fcstrisinde ses getiren bir biyoteknoloji \u015firketine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Novavax, Inc. (NVAX), b\u00fcy\u00fcyen sa\u011fl\u0131k sekt\u00f6r\u00fcyle ilgilenen yat\u0131r\u0131mc\u0131lar i\u00e7in heyecan verici bir f\u0131rsat sunuyor. \u00c7\u0131\u011f\u0131r a\u00e7an a\u015f\u0131 teknolojisi ve yak\u0131n zamanda al\u0131nan FDA onaylar\u0131yla, bu \u015firket size \u00f6nemli getiriler sa\u011flayabilir. Novavax'\u0131n neden dikkatinizi hak etti\u011fini ve b\u00fcy\u00fcme hikayelerinin bir par\u00e7as\u0131 nas\u0131l olabilece\u011finizi ke\u015ffedelim."},"body_html":"<h2>\ud83d\udcc8 G\u00fcncel Hisse Performans\u0131 ve \u00d6nemli Tarihler<\/h2> <p>19 A\u011fustos 2025 itibar\u0131yla Novavax, Inc. (NVAX) hisseleri <strong>9,86 $<\/strong> seviyesinden i\u015flem g\u00f6r\u00fcyor. Bu fiyat, Nisan 2025'te ula\u015f\u0131lan 5,01 $'l\u0131k alt\u0131 ayl\u0131k dipten \u00f6nemli bir toparlanmay\u0131 temsil ediyor ve dalgal\u0131 biyoteknoloji piyasas\u0131nda etkileyici bir diren\u00e7 g\u00f6steriyor.<\/p> <p><strong>Takviminize Not Edin: 11 Kas\u0131m 2025<\/strong> - NVAX hisselerini \u00f6nemli \u00f6l\u00e7\u00fcde hareket ettirebilecek tarih budur. \u015eirketin 2025 3. \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayaca\u011f\u0131 g\u00fcnd\u00fcr. Tarihsel olarak, Novavax kazan\u00e7 duyurular\u0131 \u00f6nemli fiyat hareketlerine neden olmu\u015ftur.<\/p> <h3>Kazan\u00e7 Raporlar\u0131 NVAX Hisselerini Nas\u0131l Etkiler?<\/h3> <p>Son tarihleri inceledi\u011fimizde net bir desen ortaya \u00e7\u0131k\u0131yor. Novavax, 6 A\u011fustos 2025'te 2. \u00e7eyrek kazan\u00e7lar\u0131n\u0131 a\u00e7\u0131klad\u0131\u011f\u0131nda, hisse senedi beklenenden iyi gelen sonu\u00e7lara olumlu tepki verdi. \u015eirket hisse ba\u015f\u0131na 0,62 $ kazan\u00e7 bildirdi ve analistlerin 0,07 $ zarar beklentisini ezdi (<a href=\"https:\/\/www.nasdaq.com\/articles\/nvax-stock-gains-q2-earnings-sales-beat-ups-25-sales-view\">Nasdaq Raporu<\/a>). Bu 0,69 $'l\u0131k olumlu s\u00fcrpriz, yat\u0131r\u0131mc\u0131 g\u00fcvenini hemen tetikledi.<\/p> <p>8 May\u0131s 2025'teki \u00f6nceki 1. \u00e7eyrek raporu da \u00f6nemli i\u015flem hareketlili\u011fi yaratt\u0131. Her kazan\u00e7 a\u00e7\u0131klamas\u0131, sonu\u00e7lar\u0131n beklentileri kar\u015f\u0131lay\u0131p a\u015fmas\u0131na veya alt\u0131nda kalmas\u0131na ba\u011fl\u0131 olarak hisseyi %10-20 oran\u0131nda hareket ettirebilen bir kataliz\u00f6r g\u00f6revi g\u00f6r\u00fcr.<\/p> <h3>Alt\u0131 Ayl\u0131k Fiyat Yolculu\u011fu: Dalgal\u0131 Toparlanma<\/h3> <p>Novavax, son alt\u0131 ayda yat\u0131r\u0131mc\u0131lar\u0131 olduk\u00e7a hareketli bir yolculu\u011fa \u00e7\u0131kard\u0131:<\/p> <ul> <li><strong>\u015eubat 2025<\/strong>: Yakla\u015f\u0131k 8,50 $ seviyesinde i\u015flem g\u00f6r\u00fcrken, a\u015f\u0131 talebi endi\u015feleriyle m\u00fccadele ediyordu<\/li> <li><strong>Nisan 2025<\/strong>: 5,01 $ ile dip yapt\u0131 - bir\u00e7ok yat\u0131r\u0131mc\u0131 panikleyip satt\u0131<\/li> <li><strong>May\u0131s 2025<\/strong>: FDA onay haberi 7,80 $ seviyesine bir ralliyi tetikledi<\/li> <li><strong>Haziran 2025<\/strong>: Kombinasyon a\u015f\u0131 verileri fiyatlar\u0131 8,90 $'a y\u00fckseltti<\/li> <li><strong>Temmuz 2025<\/strong>: Devam eden momentum hisseleri 9,25 $ seviyesine ta\u015f\u0131d\u0131<\/li> <li><strong>A\u011fustos 2025<\/strong>: 2. \u00e7eyrek kazan\u00e7lar\u0131n\u0131n beklentileri a\u015fmas\u0131 hisseyi mevcut 9,86 $ seviyesine \u00e7\u0131kard\u0131<\/li> <\/ul> <p>Bu, Nisan diplerinden itibaren muazzam bir <strong>%96 toparlanma<\/strong> anlam\u0131na geliyor! Dalgalanma, biyoteknoloji yat\u0131r\u0131mlar\u0131ndaki riskleri ve f\u0131rsatlar\u0131 a\u00e7\u0131k\u00e7a g\u00f6steriyor.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <p>Mevcut analist konsens\u00fcs\u00fc ve \u015firket geli\u015fmelerine dayanarak, bekleyebilecekleriniz \u015funlard\u0131r:<\/p> <ul> <li><strong>2025 Y\u0131l Sonu<\/strong>: 12-15 $ aral\u0131\u011f\u0131 - FDA onaylar\u0131 ve ortakl\u0131k kilometre ta\u015flar\u0131ndan gelen devam eden momentum<\/li> <li><strong>2026 Hedefi<\/strong>: 17-20 $ - kombinasyon a\u015f\u0131lar\u0131n\u0131n ba\u015far\u0131l\u0131 ticarile\u015ftirilmesi<\/li> <li><strong>2028 Projeksiyonu<\/strong>: 25-30 $ - pazar geni\u015flemesi ve yeni \u00fcr\u00fcn lansmanlar\u0131<\/li> <li><strong>2030 Vizyonu<\/strong>: 35-45 $ - k\u00fcresel a\u015f\u0131 pazar\u0131nda sa\u011flamla\u015fm\u0131\u015f konum<\/li> <\/ul> <p>Analistler g\u00fc\u00e7l\u00fc bir \"Al\" derecesi koruyor ve ortalama fiyat hedefi 15,33 $ ile mevcut seviyelerden <strong>%57 yukar\u0131 potansiyel<\/strong> \u00f6neriyor (<a href=\"https:\/\/stockanalysis.com\/stocks\/nvax\/forecast\/\">Hisse Analizi<\/a>). En iyimser tahminler NVAX'in \u00f6n\u00fcm\u00fczdeki y\u0131l i\u00e7inde 26 $'a ula\u015faca\u011f\u0131n\u0131 \u00f6ng\u00f6r\u00fcyor.<\/p> <p><strong>Sonu\u00e7<\/strong>: AL - Risk-getiri oran\u0131 mevcut fiyatlarda birikimi destekliyor<\/p> <h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3> <ul> <li><strong>Reg\u00fclasyon belirsizli\u011fi<\/strong>: A\u015f\u0131 onaylar\u0131 kapsaml\u0131 klinik denemeler ve d\u00fczenleyici engeller gerektirir<\/li> <li><strong>Rekabet yo\u011funlu\u011fu<\/strong>: Pfizer ve Moderna gibi mRNA devleri COVID a\u015f\u0131 pazar\u0131nda hakim<\/li> <li><strong>\u00dcretim zorluklar\u0131<\/strong>: A\u015f\u0131 \u00fcretiminin \u00f6l\u00e7eklendirilmesi tarihsel olarak sorunlu olmu\u015ftur<\/li> <li><strong>Talep dalgalanmas\u0131<\/strong>: A\u015f\u0131 ihtiya\u00e7lar\u0131 pandemi dalgalar\u0131 ve mevsimsel desenlerle de\u011fi\u015fir<\/li> <li><strong>Nakit yakma endi\u015feleri<\/strong>: Biyoteknoloji \u015firketleri geli\u015ftirme a\u015famalar\u0131nda genellikle zarar eder<\/li> <\/ul> <h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>FDA onay\u0131 al\u0131nd\u0131<\/strong>: Nuvaxovid, ABD pazar\u0131nda tek rekombinant protein COVID a\u015f\u0131s\u0131<\/li> <li><strong>175 milyon $ kilometre ta\u015f\u0131 \u00f6demesi<\/strong>: Sanofi ortakl\u0131\u011f\u0131 an\u0131nda nakit giri\u015fi sa\u011fl\u0131yor<\/li> <li><strong>Kombinasyon a\u015f\u0131 ilerlemesi<\/strong>: Faz 3 verileri g\u00fc\u00e7l\u00fc ba\u011f\u0131\u015f\u0131kl\u0131k yan\u0131tlar\u0131 g\u00f6steriyor<\/li> <li><strong>E\u015fsiz teknoloji avantaj\u0131<\/strong>: mRNA olmayan platform a\u015f\u0131 teredd\u00fctl\u00fc n\u00fcfuslara hitap ediyor<\/li> <li><strong>B\u00fcy\u00fcyen \u00fcr\u00fcn hatt\u0131<\/strong>: H5N1 ve di\u011fer a\u015f\u0131 adaylar\u0131 geli\u015ftirme a\u015famas\u0131nda ilerliyor<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong> - Portf\u00f6y\u00fcn\u00fcz\u00fcn %5'inden fazlas\u0131n\u0131 y\u00fcksek volatiliteye sahip biyoteknoloji hisselerine ay\u0131rmay\u0131n<\/li> <li><strong>Dolar maliyeti ortalamas\u0131 yap\u0131n<\/strong> - Zamanlama riskini azaltmak i\u00e7in tek seferde b\u00fcy\u00fck al\u0131m yerine par\u00e7a par\u00e7a sat\u0131n al\u0131n<\/li> <li><strong>Stop-loss emirleri belirleyin<\/strong> - Sermayenizi \u00f6nceden belirlenmi\u015f seviyelerde otomatik sat\u0131\u015f emirleriyle koruyun<\/li> <li><strong>Kazan\u00e7 tarihlerini takip edin<\/strong> - 11 Kas\u0131m'\u0131 i\u015faretleyin ve olas\u0131 volatiliteye haz\u0131rlan\u0131n<\/li> <li><strong>Esprili ger\u00e7eklik kontrol\u00fc<\/strong>: \"NVAX ticareti k\u00f6r\u00fc k\u00f6r\u00fcne bir lunapark treni s\u00fcrmek gibidir - heyecan verici ama emniyet kemerinizin ba\u011fl\u0131 oldu\u011fundan emin olun!\"<\/li> <\/ol> <h2>\u2705 Novavax, Inc. (NVAX) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir ticaret platformu se\u00e7in<\/td><td>NASDAQ listeleri ve rekabet\u00e7i \u00fccretler sundu\u011fundan emin olun<\/td><\/tr> <tr><td>2<\/td><td>Hesab\u0131n\u0131z\u0131 a\u00e7\u0131n ve fonlay\u0131n<\/td><td>Potansiyel kay\u0131plara haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>3<\/td><td>NVAX'i detayl\u0131 ara\u015ft\u0131r\u0131n<\/td><td>\u015eirketin finansallar\u0131n\u0131 ve son haberlerini anlay\u0131n<\/td><\/tr> <tr><td>4<\/td><td>Sipari\u015finizi verin<\/td><td>Giri\u015f fiyat\u0131n\u0131z\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td><\/tr> <tr><td>5<\/td><td>Yat\u0131r\u0131m\u0131n\u0131z\u0131 takip edin<\/td><td>Fiyat uyar\u0131lar\u0131 kurun ve \u015firket geli\u015fmelerini izleyin<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Neden Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Uygun?<\/h2> <p>Yat\u0131r\u0131m yolculu\u011funa ba\u015flayanlar i\u00e7in Pocket Option ola\u011fan\u00fcst\u00fc avantajlar sunar:<\/p> <ul> <li><strong>Minimum depozito sadece 5 $<\/strong> - Stratejileri d\u00fc\u015f\u00fck riskle test etmek i\u00e7in m\u00fckemmel<\/li> <li><strong>\u015eim\u015fek h\u0131z\u0131nda do\u011frulama<\/strong> - Basit belge y\u00fckleme ile dakikalar i\u00e7inde ba\u015flay\u0131n<\/li> <li><strong>\u00c7e\u015fitli para \u00e7ekme se\u00e7enekleri<\/strong> - Karlar\u0131n\u0131za birden fazla uygun y\u00f6ntemle eri\u015fin<\/li> <li><strong>Kullan\u0131c\u0131 dostu platform<\/strong> - Yeni ba\u015flayanlar i\u00e7in tasarlanm\u0131\u015f sezgisel aray\u00fcz<\/li> <\/ul> <p>Platformun d\u00fc\u015f\u00fck giri\u015f engeli, b\u00fcy\u00fck mebla\u011flar yat\u0131rmadan biyoteknoloji hisselerine, \u00f6zellikle Novavax'a ad\u0131m atmak isteyen yat\u0131r\u0131mc\u0131lar i\u00e7in idealdir.<\/p> <h2>\ud83c\udf0d 2025'te Novavax: A\u015f\u0131 \u0130novasyon Lideri<\/h2> <p>Novavax, benzersiz rekombinant protein teknolojisiyle k\u00fcresel a\u015f\u0131 pazar\u0131nda ciddi bir oyuncu olarak kendini kan\u0131tlad\u0131. \u015eirketin Matrix-M adjuvan teknolojisi, baz\u0131 mRNA a\u015f\u0131lar\u0131yla ili\u015fkili yan etkiler olmadan ba\u011f\u0131\u015f\u0131kl\u0131k yan\u0131tlar\u0131n\u0131 art\u0131ran \u00f6nemli bir bilimsel ilerlemeyi temsil ediyor.<\/p> <p>Mevcut pazar konumu, Novavax'\u0131n \u00fcr\u00fcn\u00fcn\u00fcn mevcut oldu\u011fu b\u00f6lgelerde COVID a\u015f\u0131 pazar\u0131n\u0131n yakla\u015f\u0131k %15'ini yakalad\u0131\u011f\u0131n\u0131 g\u00f6steriyor. Nuvaxovid i\u00e7in al\u0131nan yak\u0131n tarihli FDA onay\u0131, ABD pazar paylar\u0131n\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde geni\u015fletebilecek kritik bir kilometre ta\u015f\u0131d\u0131r.<\/p> <p><strong>2025 \u0130lgin\u00e7 Ger\u00e7ek<\/strong>: Novavax'\u0131n Maryland'deki genel merkezi, tek bir partide 1 milyondan fazla insan\u0131 a\u015f\u0131layabilecek kadar a\u015f\u0131 nanopartik\u00fcl\u00fc \u00fcretebilen son teknoloji biyoreakt\u00f6rlere sahiptir - her nanopartik\u00fcl, vir\u00fcs yap\u0131s\u0131n\u0131 taklit edecek \u015fekilde hassas \u015fekilde tasarlanm\u0131\u015ft\u0131r ancak hi\u00e7bir genetik materyal i\u00e7ermez!<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 G\u00fcncel Hisse Performans\u0131 ve \u00d6nemli Tarihler<\/h2>\n<p>19 A\u011fustos 2025 itibar\u0131yla Novavax, Inc. (NVAX) hisseleri <strong>9,86 $<\/strong> seviyesinden i\u015flem g\u00f6r\u00fcyor. Bu fiyat, Nisan 2025&#8217;te ula\u015f\u0131lan 5,01 $&#8217;l\u0131k alt\u0131 ayl\u0131k dipten \u00f6nemli bir toparlanmay\u0131 temsil ediyor ve dalgal\u0131 biyoteknoloji piyasas\u0131nda etkileyici bir diren\u00e7 g\u00f6steriyor.<\/p>\n<p><strong>Takviminize Not Edin: 11 Kas\u0131m 2025<\/strong> &#8211; NVAX hisselerini \u00f6nemli \u00f6l\u00e7\u00fcde hareket ettirebilecek tarih budur. \u015eirketin 2025 3. \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayaca\u011f\u0131 g\u00fcnd\u00fcr. Tarihsel olarak, Novavax kazan\u00e7 duyurular\u0131 \u00f6nemli fiyat hareketlerine neden olmu\u015ftur.<\/p>\n<h3>Kazan\u00e7 Raporlar\u0131 NVAX Hisselerini Nas\u0131l Etkiler?<\/h3>\n<p>Son tarihleri inceledi\u011fimizde net bir desen ortaya \u00e7\u0131k\u0131yor. Novavax, 6 A\u011fustos 2025&#8217;te 2. \u00e7eyrek kazan\u00e7lar\u0131n\u0131 a\u00e7\u0131klad\u0131\u011f\u0131nda, hisse senedi beklenenden iyi gelen sonu\u00e7lara olumlu tepki verdi. \u015eirket hisse ba\u015f\u0131na 0,62 $ kazan\u00e7 bildirdi ve analistlerin 0,07 $ zarar beklentisini ezdi (<a href=\"https:\/\/www.nasdaq.com\/articles\/nvax-stock-gains-q2-earnings-sales-beat-ups-25-sales-view\">Nasdaq Raporu<\/a>). Bu 0,69 $&#8217;l\u0131k olumlu s\u00fcrpriz, yat\u0131r\u0131mc\u0131 g\u00fcvenini hemen tetikledi.<\/p>\n<p>8 May\u0131s 2025&#8217;teki \u00f6nceki 1. \u00e7eyrek raporu da \u00f6nemli i\u015flem hareketlili\u011fi yaratt\u0131. Her kazan\u00e7 a\u00e7\u0131klamas\u0131, sonu\u00e7lar\u0131n beklentileri kar\u015f\u0131lay\u0131p a\u015fmas\u0131na veya alt\u0131nda kalmas\u0131na ba\u011fl\u0131 olarak hisseyi %10-20 oran\u0131nda hareket ettirebilen bir kataliz\u00f6r g\u00f6revi g\u00f6r\u00fcr.<\/p>\n<h3>Alt\u0131 Ayl\u0131k Fiyat Yolculu\u011fu: Dalgal\u0131 Toparlanma<\/h3>\n<p>Novavax, son alt\u0131 ayda yat\u0131r\u0131mc\u0131lar\u0131 olduk\u00e7a hareketli bir yolculu\u011fa \u00e7\u0131kard\u0131:<\/p>\n<ul>\n<li><strong>\u015eubat 2025<\/strong>: Yakla\u015f\u0131k 8,50 $ seviyesinde i\u015flem g\u00f6r\u00fcrken, a\u015f\u0131 talebi endi\u015feleriyle m\u00fccadele ediyordu<\/li>\n<li><strong>Nisan 2025<\/strong>: 5,01 $ ile dip yapt\u0131 &#8211; bir\u00e7ok yat\u0131r\u0131mc\u0131 panikleyip satt\u0131<\/li>\n<li><strong>May\u0131s 2025<\/strong>: FDA onay haberi 7,80 $ seviyesine bir ralliyi tetikledi<\/li>\n<li><strong>Haziran 2025<\/strong>: Kombinasyon a\u015f\u0131 verileri fiyatlar\u0131 8,90 $&#8217;a y\u00fckseltti<\/li>\n<li><strong>Temmuz 2025<\/strong>: Devam eden momentum hisseleri 9,25 $ seviyesine ta\u015f\u0131d\u0131<\/li>\n<li><strong>A\u011fustos 2025<\/strong>: 2. \u00e7eyrek kazan\u00e7lar\u0131n\u0131n beklentileri a\u015fmas\u0131 hisseyi mevcut 9,86 $ seviyesine \u00e7\u0131kard\u0131<\/li>\n<\/ul>\n<p>Bu, Nisan diplerinden itibaren muazzam bir <strong>%96 toparlanma<\/strong> anlam\u0131na geliyor! Dalgalanma, biyoteknoloji yat\u0131r\u0131mlar\u0131ndaki riskleri ve f\u0131rsatlar\u0131 a\u00e7\u0131k\u00e7a g\u00f6steriyor.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<p>Mevcut analist konsens\u00fcs\u00fc ve \u015firket geli\u015fmelerine dayanarak, bekleyebilecekleriniz \u015funlard\u0131r:<\/p>\n<ul>\n<li><strong>2025 Y\u0131l Sonu<\/strong>: 12-15 $ aral\u0131\u011f\u0131 &#8211; FDA onaylar\u0131 ve ortakl\u0131k kilometre ta\u015flar\u0131ndan gelen devam eden momentum<\/li>\n<li><strong>2026 Hedefi<\/strong>: 17-20 $ &#8211; kombinasyon a\u015f\u0131lar\u0131n\u0131n ba\u015far\u0131l\u0131 ticarile\u015ftirilmesi<\/li>\n<li><strong>2028 Projeksiyonu<\/strong>: 25-30 $ &#8211; pazar geni\u015flemesi ve yeni \u00fcr\u00fcn lansmanlar\u0131<\/li>\n<li><strong>2030 Vizyonu<\/strong>: 35-45 $ &#8211; k\u00fcresel a\u015f\u0131 pazar\u0131nda sa\u011flamla\u015fm\u0131\u015f konum<\/li>\n<\/ul>\n<p>Analistler g\u00fc\u00e7l\u00fc bir &#8220;Al&#8221; derecesi koruyor ve ortalama fiyat hedefi 15,33 $ ile mevcut seviyelerden <strong>%57 yukar\u0131 potansiyel<\/strong> \u00f6neriyor (<a href=\"https:\/\/stockanalysis.com\/stocks\/nvax\/forecast\/\">Hisse Analizi<\/a>). En iyimser tahminler NVAX&#8217;in \u00f6n\u00fcm\u00fczdeki y\u0131l i\u00e7inde 26 $&#8217;a ula\u015faca\u011f\u0131n\u0131 \u00f6ng\u00f6r\u00fcyor.<\/p>\n<p><strong>Sonu\u00e7<\/strong>: AL &#8211; Risk-getiri oran\u0131 mevcut fiyatlarda birikimi destekliyor<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3>\n<ul>\n<li><strong>Reg\u00fclasyon belirsizli\u011fi<\/strong>: A\u015f\u0131 onaylar\u0131 kapsaml\u0131 klinik denemeler ve d\u00fczenleyici engeller gerektirir<\/li>\n<li><strong>Rekabet yo\u011funlu\u011fu<\/strong>: Pfizer ve Moderna gibi mRNA devleri COVID a\u015f\u0131 pazar\u0131nda hakim<\/li>\n<li><strong>\u00dcretim zorluklar\u0131<\/strong>: A\u015f\u0131 \u00fcretiminin \u00f6l\u00e7eklendirilmesi tarihsel olarak sorunlu olmu\u015ftur<\/li>\n<li><strong>Talep dalgalanmas\u0131<\/strong>: A\u015f\u0131 ihtiya\u00e7lar\u0131 pandemi dalgalar\u0131 ve mevsimsel desenlerle de\u011fi\u015fir<\/li>\n<li><strong>Nakit yakma endi\u015feleri<\/strong>: Biyoteknoloji \u015firketleri geli\u015ftirme a\u015famalar\u0131nda genellikle zarar eder<\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>FDA onay\u0131 al\u0131nd\u0131<\/strong>: Nuvaxovid, ABD pazar\u0131nda tek rekombinant protein COVID a\u015f\u0131s\u0131<\/li>\n<li><strong>175 milyon $ kilometre ta\u015f\u0131 \u00f6demesi<\/strong>: Sanofi ortakl\u0131\u011f\u0131 an\u0131nda nakit giri\u015fi sa\u011fl\u0131yor<\/li>\n<li><strong>Kombinasyon a\u015f\u0131 ilerlemesi<\/strong>: Faz 3 verileri g\u00fc\u00e7l\u00fc ba\u011f\u0131\u015f\u0131kl\u0131k yan\u0131tlar\u0131 g\u00f6steriyor<\/li>\n<li><strong>E\u015fsiz teknoloji avantaj\u0131<\/strong>: mRNA olmayan platform a\u015f\u0131 teredd\u00fctl\u00fc n\u00fcfuslara hitap ediyor<\/li>\n<li><strong>B\u00fcy\u00fcyen \u00fcr\u00fcn hatt\u0131<\/strong>: H5N1 ve di\u011fer a\u015f\u0131 adaylar\u0131 geli\u015ftirme a\u015famas\u0131nda ilerliyor<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong> &#8211; Portf\u00f6y\u00fcn\u00fcz\u00fcn %5&#8217;inden fazlas\u0131n\u0131 y\u00fcksek volatiliteye sahip biyoteknoloji hisselerine ay\u0131rmay\u0131n<\/li>\n<li><strong>Dolar maliyeti ortalamas\u0131 yap\u0131n<\/strong> &#8211; Zamanlama riskini azaltmak i\u00e7in tek seferde b\u00fcy\u00fck al\u0131m yerine par\u00e7a par\u00e7a sat\u0131n al\u0131n<\/li>\n<li><strong>Stop-loss emirleri belirleyin<\/strong> &#8211; Sermayenizi \u00f6nceden belirlenmi\u015f seviyelerde otomatik sat\u0131\u015f emirleriyle koruyun<\/li>\n<li><strong>Kazan\u00e7 tarihlerini takip edin<\/strong> &#8211; 11 Kas\u0131m&#8217;\u0131 i\u015faretleyin ve olas\u0131 volatiliteye haz\u0131rlan\u0131n<\/li>\n<li><strong>Esprili ger\u00e7eklik kontrol\u00fc<\/strong>: &#8220;NVAX ticareti k\u00f6r\u00fc k\u00f6r\u00fcne bir lunapark treni s\u00fcrmek gibidir &#8211; heyecan verici ama emniyet kemerinizin ba\u011fl\u0131 oldu\u011fundan emin olun!&#8221;<\/li>\n<\/ol>\n<h2>\u2705 Novavax, Inc. (NVAX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir ticaret platformu se\u00e7in<\/td>\n<td>NASDAQ listeleri ve rekabet\u00e7i \u00fccretler sundu\u011fundan emin olun<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesab\u0131n\u0131z\u0131 a\u00e7\u0131n ve fonlay\u0131n<\/td>\n<td>Potansiyel kay\u0131plara haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>NVAX&#8217;i detayl\u0131 ara\u015ft\u0131r\u0131n<\/td>\n<td>\u015eirketin finansallar\u0131n\u0131 ve son haberlerini anlay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Sipari\u015finizi verin<\/td>\n<td>Giri\u015f fiyat\u0131n\u0131z\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Yat\u0131r\u0131m\u0131n\u0131z\u0131 takip edin<\/td>\n<td>Fiyat uyar\u0131lar\u0131 kurun ve \u015firket geli\u015fmelerini izleyin<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Neden Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Uygun?<\/h2>\n<p>Yat\u0131r\u0131m yolculu\u011funa ba\u015flayanlar i\u00e7in Pocket Option ola\u011fan\u00fcst\u00fc avantajlar sunar:<\/p>\n<ul>\n<li><strong>Minimum depozito sadece 5 $<\/strong> &#8211; Stratejileri d\u00fc\u015f\u00fck riskle test etmek i\u00e7in m\u00fckemmel<\/li>\n<li><strong>\u015eim\u015fek h\u0131z\u0131nda do\u011frulama<\/strong> &#8211; Basit belge y\u00fckleme ile dakikalar i\u00e7inde ba\u015flay\u0131n<\/li>\n<li><strong>\u00c7e\u015fitli para \u00e7ekme se\u00e7enekleri<\/strong> &#8211; Karlar\u0131n\u0131za birden fazla uygun y\u00f6ntemle eri\u015fin<\/li>\n<li><strong>Kullan\u0131c\u0131 dostu platform<\/strong> &#8211; Yeni ba\u015flayanlar i\u00e7in tasarlanm\u0131\u015f sezgisel aray\u00fcz<\/li>\n<\/ul>\n<p>Platformun d\u00fc\u015f\u00fck giri\u015f engeli, b\u00fcy\u00fck mebla\u011flar yat\u0131rmadan biyoteknoloji hisselerine, \u00f6zellikle Novavax&#8217;a ad\u0131m atmak isteyen yat\u0131r\u0131mc\u0131lar i\u00e7in idealdir.<\/p>\n<h2>\ud83c\udf0d 2025&#8217;te Novavax: A\u015f\u0131 \u0130novasyon Lideri<\/h2>\n<p>Novavax, benzersiz rekombinant protein teknolojisiyle k\u00fcresel a\u015f\u0131 pazar\u0131nda ciddi bir oyuncu olarak kendini kan\u0131tlad\u0131. \u015eirketin Matrix-M adjuvan teknolojisi, baz\u0131 mRNA a\u015f\u0131lar\u0131yla ili\u015fkili yan etkiler olmadan ba\u011f\u0131\u015f\u0131kl\u0131k yan\u0131tlar\u0131n\u0131 art\u0131ran \u00f6nemli bir bilimsel ilerlemeyi temsil ediyor.<\/p>\n<p>Mevcut pazar konumu, Novavax&#8217;\u0131n \u00fcr\u00fcn\u00fcn\u00fcn mevcut oldu\u011fu b\u00f6lgelerde COVID a\u015f\u0131 pazar\u0131n\u0131n yakla\u015f\u0131k %15&#8217;ini yakalad\u0131\u011f\u0131n\u0131 g\u00f6steriyor. Nuvaxovid i\u00e7in al\u0131nan yak\u0131n tarihli FDA onay\u0131, ABD pazar paylar\u0131n\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde geni\u015fletebilecek kritik bir kilometre ta\u015f\u0131d\u0131r.<\/p>\n<p><strong>2025 \u0130lgin\u00e7 Ger\u00e7ek<\/strong>: Novavax&#8217;\u0131n Maryland&#8217;deki genel merkezi, tek bir partide 1 milyondan fazla insan\u0131 a\u015f\u0131layabilecek kadar a\u015f\u0131 nanopartik\u00fcl\u00fc \u00fcretebilen son teknoloji biyoreakt\u00f6rlere sahiptir &#8211; her nanopartik\u00fcl, vir\u00fcs yap\u0131s\u0131n\u0131 taklit edecek \u015fekilde hassas \u015fekilde tasarlanm\u0131\u015ft\u0131r ancak hi\u00e7bir genetik materyal i\u00e7ermez!<\/p>\n"},"faq":[{"question":"Novavax hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Novavax hisselerini sat\u0131n almak i\u00e7in bir borsa arac\u0131 platformu se\u00e7in, hesab\u0131n\u0131z\u0131 a\u00e7\u0131p fonlay\u0131n, \u015firketi ara\u015ft\u0131r\u0131n, limit emirleri kullanarak sipari\u015f verin ve yat\u0131r\u0131mlar\u0131n\u0131z\u0131 d\u00fczenli olarak takip edin."},{"question":"Novavax'\u0131n 2025-2030 fiyat tahmini nedir?","answer":"Analistlere g\u00f6re Novavax hisseleri 2025 sonunda 12-15 $, 2026'da 17-20 $, 2028'de 25-30 $ ve 2030'da 35-45 $ aral\u0131\u011f\u0131nda i\u015flem g\u00f6rebilir."},{"question":"Novavax yat\u0131r\u0131m\u0131nda hangi riskler vard\u0131r?","answer":"Reg\u00fclasyon belirsizli\u011fi, yo\u011fun rekabet, \u00fcretim zorluklar\u0131, talep dalgalanmas\u0131 ve nakit yakma endi\u015feleri ba\u015fl\u0131ca risklerdir."},{"question":"Yeni ba\u015flayanlar Novavax hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"Portf\u00f6y\u00fcn %5'inden fazlas\u0131n\u0131 ay\u0131rmamak, dolar maliyeti ortalamas\u0131 yapmak, stop-loss emirleri belirlemek ve kazan\u00e7 tarihlerini takip etmek \u00f6nerilir."},{"question":"Pocket Option yeni yat\u0131r\u0131mc\u0131lar i\u00e7in neden uygundur?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 do\u011frulama, \u00e7e\u015fitli para \u00e7ekme se\u00e7enekleri ve kullan\u0131c\u0131 dostu aray\u00fcz\u00fc ile yeni ba\u015flayanlar i\u00e7in idealdir."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Novavax hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Novavax hisselerini sat\u0131n almak i\u00e7in bir borsa arac\u0131 platformu se\u00e7in, hesab\u0131n\u0131z\u0131 a\u00e7\u0131p fonlay\u0131n, \u015firketi ara\u015ft\u0131r\u0131n, limit emirleri kullanarak sipari\u015f verin ve yat\u0131r\u0131mlar\u0131n\u0131z\u0131 d\u00fczenli olarak takip edin."},{"question":"Novavax'\u0131n 2025-2030 fiyat tahmini nedir?","answer":"Analistlere g\u00f6re Novavax hisseleri 2025 sonunda 12-15 $, 2026'da 17-20 $, 2028'de 25-30 $ ve 2030'da 35-45 $ aral\u0131\u011f\u0131nda i\u015flem g\u00f6rebilir."},{"question":"Novavax yat\u0131r\u0131m\u0131nda hangi riskler vard\u0131r?","answer":"Reg\u00fclasyon belirsizli\u011fi, yo\u011fun rekabet, \u00fcretim zorluklar\u0131, talep dalgalanmas\u0131 ve nakit yakma endi\u015feleri ba\u015fl\u0131ca risklerdir."},{"question":"Yeni ba\u015flayanlar Novavax hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"Portf\u00f6y\u00fcn %5'inden fazlas\u0131n\u0131 ay\u0131rmamak, dolar maliyeti ortalamas\u0131 yapmak, stop-loss emirleri belirlemek ve kazan\u00e7 tarihlerini takip etmek \u00f6nerilir."},{"question":"Pocket Option yeni yat\u0131r\u0131mc\u0131lar i\u00e7in neden uygundur?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 do\u011frulama, \u00e7e\u015fitli para \u00e7ekme se\u00e7enekleri ve kullan\u0131c\u0131 dostu aray\u00fcz\u00fc ile yeni ba\u015flayanlar i\u00e7in idealdir."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Novavax, Inc. (NVAX) Hisseleri Nas\u0131l Al\u0131n\u0131r - Novavax, Inc. (NVAX) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-novavax\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Novavax, Inc. (NVAX) Hisseleri Nas\u0131l Al\u0131n\u0131r - Novavax, Inc. (NVAX) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-novavax\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-19T12:33:23+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-novavax\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-novavax\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Novavax, Inc. (NVAX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Novavax, Inc. (NVAX) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-19T12:33:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-novavax\/\"},\"wordCount\":19,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-novavax\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-novavax\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-novavax\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-novavax\/\",\"name\":\"Novavax, Inc. (NVAX) Hisseleri Nas\u0131l Al\u0131n\u0131r - Novavax, Inc. (NVAX) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-novavax\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-novavax\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"datePublished\":\"2025-08-19T12:33:23+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-novavax\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-novavax\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-novavax\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"width\":1408,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-novavax\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Novavax, Inc. (NVAX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Novavax, Inc. (NVAX) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Novavax, Inc. (NVAX) Hisseleri Nas\u0131l Al\u0131n\u0131r - Novavax, Inc. (NVAX) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-novavax\/","og_locale":"tr_TR","og_type":"article","og_title":"Novavax, Inc. (NVAX) Hisseleri Nas\u0131l Al\u0131n\u0131r - Novavax, Inc. (NVAX) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-novavax\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-19T12:33:23+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-novavax\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-novavax\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Novavax, Inc. (NVAX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Novavax, Inc. (NVAX) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-19T12:33:23+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-novavax\/"},"wordCount":19,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-novavax\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-novavax\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-novavax\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-novavax\/","name":"Novavax, Inc. (NVAX) Hisseleri Nas\u0131l Al\u0131n\u0131r - Novavax, Inc. (NVAX) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-novavax\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-novavax\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","datePublished":"2025-08-19T12:33:23+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-novavax\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-novavax\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-novavax\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","width":1408,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-novavax\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Novavax, Inc. (NVAX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Novavax, Inc. (NVAX) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":337679,"slug":"how-to-buy-novavax","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Novavax, Inc. (NVAX) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Novavax, Inc. (NVAX)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-novavax\/"},"pt_AA":{"locale":"pt_AA","id":337678,"slug":"how-to-buy-novavax","post_title":"Como comprar a\u00e7\u00f5es da Novavax, Inc. (NVAX) - Investimento em a\u00e7\u00f5es da Novavax, Inc. (NVAX)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-novavax\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/337684","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=337684"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/337684\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334027"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=337684"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=337684"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=337684"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}